Duke Cancer Institute at Cary: Medical Oncology — Cary, North Carolina

Duke Cancer Institute at Cary: Medical Oncology is a clinical research site located in Cary, North Carolina, United States 27518.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Cancer Institute at Cary: Medical Oncology has participated in 1 clinical trials.

Therapeutic areas: Castration-resistant Prostate Cancer, CRPC.

Sponsors: Innocrin Pharmaceutical.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Institute at Cary: Medical Oncology?

Duke Cancer Institute at Cary: Medical Oncology has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Institute at Cary: Medical Oncology conducted?

Duke Cancer Institute at Cary: Medical Oncology has 1 clinical trials on record. Their work covers Castration-resistant Prostate Cancer, CRPC.

Is Duke Cancer Institute at Cary: Medical Oncology accredited by Crixeo Health?

Duke Cancer Institute at Cary: Medical Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Institute at Cary: Medical Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.